Reports of SSRI-associated bruxism in the family physician's office.
OBJECTIVE
Recently, the use of selective serotonin reuptake inhibitors (SSRIs) has been associated with the occurrence or worsening of bruxism. The aim of this study was to obtain a first indication of the prevalence of SSRI-associated bruxism reported to family physicians, the main prescribers of SSRIs.


METHODS
A questionnaire, with questions about prescription rate, already registered adverse reactions, and bruxism-related side effects of 4 different types of SSRIs, was sent to all family physicians in greater Amsterdam (n = 391).


RESULTS
With a response rate of 42.5%, frequent observations of already registered side effects were found. In addition, 5 family physicians (3.2%) reported the occurrence of bruxism in relation to the use of SSRIs.


CONCLUSIONS
The use of SSRIs might be associated with the occurrence of bruxism. A case report is provided that corroborates this suggestion.
Lobbezoo
F
F
Department of Oral Function, Academic Centre for Dentistry Amsterdam (ACTA), Louwesweg 1, 1066 EA Amsterdam, The Netherlands. f.lobbezoo@acta.nl
van Denderen
R J
RJ
Verheij
J G
JG
Naeije
M
M
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D002012:Bruxism / Q000139:chemically induced*; D016903:Drug Monitoring; D011307:Drug Prescriptions; D005194:Family Practice; D005260:Female; D006801:Humans; D009426:Netherlands; D017374:Paroxetine / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D011795:Surveys and Questionnaires
D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors